Drug Shortage Report for VIRACEPT
Report ID | 137908 |
Drug Identification Number | 02248761 |
Brand name | VIRACEPT |
Common or Proper name | Viracept |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NELFINAVIR |
Strength(s) | 625MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 120 count bottle |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-31 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2021-09-01 |
Shortage status | Avoided shortage |
Updated date | 2021-09-03 |
Company comments | Distributed by ViiV Healthcare. Product is being discontinued (Please refer to Report ID# 145167) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-21 | English | Compare |
v2 | 2021-04-21 | French | Compare |
v3 | 2021-07-08 | English | Compare |
v4 | 2021-07-08 | French | Compare |
v5 | 2021-09-03 | English | Compare |
v6 | 2021-09-03 | French | Compare |
Showing 1 to 6 of 6